Access to Treatment

Esbriet™ (pirfenidone) is an anti-fibrotic/anti-inflammatory agent approved by Health Canada for the treatment of mild to moderate idiopathic pulmonary fibrosis in adults.

The Inspiration™ Patient Assistance Program is a multi-faceted patient support program offered by InterMune Canada Inc. for patients prescribed Esbriet™ (pirfenidone).  Nurses are available to answer your questions Monday to Friday, 8am to 8pm EST at: 1-855-5-IPF CARE (1-855-547-3227).